Christopher G. Rowan
Also known as: Chris Rowan, Christopher G. Rowan, Christopher George Rowan
Veritas Research Foundation, COHRDATA, INC, Uiversity of Pennsylvania, University of Michigan–Ann Arbor, Rutgers University
0000-0002-4318-2970
About
Christopher G. Rowan PhD (Chris) is the Founder and Principal Investigator of the Veritas Research Foundation (501(c)(3)) and COHRDATA, INC. He is also an Adjunct Associate Professor at Rutgers University Center for Pharmacoepidemiology and Treatment Science (PETS) and pharmacoepidemiologist, biostatistician, and drug safety researcher by training. He has extensive experience using comparative methods to estimate causal relationships between medication exposure and adverse drug events (ADEs). His research vision is to safeguard public health using innovative strategies to detect, quantify, and confirm drug related harm.
Chris is experienced in designing and executing retrospective, observational drug safety studies using electronic health record (EHR) and health insurance claims databases – in a variety of disease and therapeutic areas. His recent publications include comparative safety/effectiveness research, predictive modeling studies, and methodologic investigations. His research proficiencies include advanced study design and analytic approaches to address confounding and selection bias, interpretation of research findings, and dissemination through peer reviewed publications (abstracts and manuscripts). Chris has a strong publication track record and several ongoing collaborations with industry partners, academic researchers, and non-profit organizations.
Chris received his Doctor of Philosophy in Epidemiology with a minor in Biostatistics (specialty in pharmacoepidemiology) from the University of Pennsylvania. He received the 2010 Saul Winegrad award for outstanding dissertation. Chris also conducted a pre-doctoral fellowship at the FDA in the Division of Drug Risk Evaluation. He is an active member of the International Society of Pharmacoepidemiology (ISPE) and serves as a regular reviewer for Pharmacoepidemiology and Drug Safety (PDS) and other prominent medical journals.
Employment
-
Veritas Research Foundation Principal Investigator2022 - Present
-
COHRDATA, INC Pharmacoepidemiologist/Founder2016 - Present
-
Rutgers University Adjunct Associate Professor2014 - Present
Education
-
Uiversity of Pennsylvania PhD2005 - 2010
-
University of Michigan–Ann Arbor Bachelor of Science1990 - 1993
Projects & Funding
Projects & funding information is unavailable.
Publications (49)
- Integrating Causal Inference into Pharmacovigilance: Target Trial Emulations for Proactive Signal Detection of Atorvastatin Initiation in Medicare Beneficiaries Save
- Beyond Signal Detection: Sequential Target Trial Emulations to Confirm Previously Detected Adverse Drug Event Signals for Atorvastatin in Older Medicare Beneficiaries Save
- Can Predictive Modeling Inform the Selection of Time Zero for Target Trial Emulations? An Empirical Study of Atorvastatin Initiation in Medicare Beneficiaries Save
- Medication Use in Medicare Beneficiaries: A Platform for Real-World Pharmacovigilance and Drug Safety Research Save
- Real-World Effectiveness of Bebtelovimab Versus Nirmatrelvir/Ritonavir in Outpatients with COVID-19 Save
- Proactive Adverse Drug Event Signal Detection: A Self-Controlled Cohort Study of Elderly Atorvastatin Initiators Save
- Healthcare utilization and expenditures associated with hyperkalemia management: a retrospective study of Medicare Advantage patients Save
- Hospital and Emergency Department Utilization in US Veterans with Hyperkalemia Save
- Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization Save
- Real-World Assessment of Health Care Costs for Patients with Metastatic Pancreatic Cancer Following Initiation First-Line Chemotherapy Save